Publications (26) ANTONIO DOMINGUEZ MEIJIDE publications

2024

  1. Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission

    npj Parkinson's Disease, Vol. 10, Núm. 1

2022

  1. Anatomía general y anatomía del aparato locomotor

    Campus na Nube

  2. Endogenous Levels of Alpha-Synuclein Modulate Seeding and Aggregation in Cultured Cells

    Molecular Neurobiology, Vol. 59, Núm. 2, pp. 1273-1284

  3. Glycation modulates alpha-synuclein fibrillization kinetics: A sweet spot for inhibition

    Journal of Biological Chemistry, Vol. 298, Núm. 5

2021

  1. Doxycycline Interferes With Tau Aggregation and Reduces Its Neuronal Toxicity

    Frontiers in Aging Neuroscience, Vol. 13

  2. Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo

    Neurobiology of Disease, Vol. 151

2020

  1. Aging-Related Overactivity of the Angiotensin/AT1 Axis Decreases Sirtuin 3 Levels in the Substantia Nigra, Which Induces Vulnerability to Oxidative Stress and Neurodegeneration

    The journals of gerontology. Series A, Biological sciences and medical sciences, Vol. 75, Núm. 3, pp. 416-424

  2. Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization

    Scientific Reports, Vol. 10, Núm. 1

  3. Pharmacological modulators of tau aggregation and spreading

    Brain Sciences, Vol. 10, Núm. 11, pp. 1-29

  4. Synucleinopathies: Where we are and where we need to go

    Journal of Neurochemistry, Vol. 153, Núm. 4, pp. 433-454

2019

  1. Cytosolic Trapping of a Mitochondrial Heat Shock Protein Is an Early Pathological Event in Synucleinopathies

    Cell Reports, Vol. 28, Núm. 1, pp. 65-77.e6

  2. LRRK2, alpha-synuclein, and tau: Partners in crime or unfortunate bystanders?

    Biochemical Society Transactions, Vol. 47, Núm. 3, pp. 827-838

  3. Spreading of α-synuclein and tau: A systematic comparison of the mechanisms involved

    Frontiers in Molecular Neuroscience, Vol. 12

  4. Synthesis and evaluation of esterified Hsp70 agonists in cellular models of protein aggregation and folding

    Bioorganic and Medicinal Chemistry, Vol. 27, Núm. 1, pp. 79-91

2018

  1. Aging-related dysregulation in enteric dopamine and angiotensin system interactions: Implications for gastrointestinal dysfunction in the elderly

    Oncotarget, Vol. 9, Núm. 13, pp. 10834-10846

  2. Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson’s Disease Models

    Molecular Neurobiology, Vol. 55, Núm. 9, pp. 7297-7316

2017

  1. Dopamine modulates astroglial and microglial activity via glial renin-angiotensin system in cultures

    Brain, Behavior, and Immunity, Vol. 62, pp. 277-290

2015

  1. Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinsons Disease

    Neuroscientist, Vol. 21, Núm. 6, pp. 616-629

2014

  1. Aging-related dysregulation of dopamine and angiotensin receptor interaction

    Neurobiology of Aging, Vol. 35, Núm. 7, pp. 1726-1738

  2. Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1β

    Experimental Neurology, Vol. 261, pp. 720-732